LEVIN MICHAELA (Chief Business Officer) received a stock award from ACRIVON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/2/2026ACC: 0000905148-26-004065
Officer· Chief Business Officer
Since Aug 2026
+160K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
160K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
New position
8/31/2026
0.00→30K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2026 | A · Award | +30K | — | — | New position | 0.00 | 30K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
130K shares
Shares
+130K
Strike price
2.09
Held after
130K
Exercisable
—
8/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock130K shares | 8/31/2026 | A · Award | +130K | 2.09 | — | 130K |